Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
14,866
datasets available to search
ShareScore release 0.9.0
Dataset results
14,866 results for “cancer cell”
Diagnostic Value of C-reactive Protein and White Blood Cell Counts for Early Detection of Inflammatory Complications After Open Resection of Colorectal Cancer
ClinicalTrials.gov study NCT01221324. IPD Sharing: Not stated. Countries: 0. Publications: 1.
Broccoli Sprout Extract in Treating Patients With Transitional Cell Bladder Cancer Undergoing Surgery
ClinicalTrials.gov study NCT01108003. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Imatinib Mesylate (Gleevec) and Docetaxel in Patients With Head and Neck Squamous Cell Cancer
ClinicalTrials.gov study NCT00485485. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Atezolizumab and Tiragolumab Compared With Durvalumab in Participants With Locally Advanced, Unresectable Stage III Non-Small Cell Lung Cancer (NSCLC)
ClinicalTrials.gov study NCT04513925. IPD Sharing: YES. Countries: 26. Publications: 0.
Pilot Study of Preoperative Tarceva (Erlotinib) for Stages I/II Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT00385996. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Anetumab Ravtansine and Atezolizumab in Treating Participants With Advanced Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT03455556. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase II Study of Radiation Therapy, Paclitaxel Poliglumex, and Carboplatin in Stage III Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT00352690. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase III Study to Determine Efficacy of Durvalumab in Stage II-III Non-small Cell Lung Cancer (NSCLC) After Curative Intent Therapy.
ClinicalTrials.gov study NCT04642469. IPD Sharing: YES. Countries: 25. Publications: 0.
Study of Pralatrexate vs. Erlotinib for Non-Small Cell Lung Cancer After at Least 1 Prior Platinum-based Treatment
ClinicalTrials.gov study NCT00606502. IPD Sharing: Not stated. Countries: 6. Publications: 0.
BEPACT- Lung: Impact of Patient Characteristics on Pneumo-oncologists Non Small Cell Lung Cancer (NSCLC) Systemic Treatment Decision in Belgium
ClinicalTrials.gov study NCT03959137. IPD Sharing: NO. Countries: 1. Publications: 0.
Docetaxel With or Without FGFR Inhibitor AZD4547 in Treating Patients With Recurrent Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT01824901. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of Cixutumumab (IMC-A12) in Islet Cell Cancer
ClinicalTrials.gov study NCT00781911. IPD Sharing: YES. Countries: 1. Publications: 0.
Panitumumab-IRDye800 and 89Zr-Panitumumab in Identifying Metastatic Lymph Nodes in Patients With Squamous Cell Head and Neck Cancer
ClinicalTrials.gov study NCT03733210. IPD Sharing: NO. Countries: 1. Publications: 0.
Efficacy of Doxycycline on Metakaryote Cell Death in Patients With Resectable Pancreatic Cancer
ClinicalTrials.gov study NCT02775695. IPD Sharing: NO. Countries: 1. Publications: 0.
Bendamustine With Irinotecan Followed by Etoposide/Carboplatin for Patients With Extensive Stage Small Cell Lung Cancer
ClinicalTrials.gov study NCT00856830. IPD Sharing: NO. Countries: 1. Publications: 0.
Anlotinib Hydrochloride Combined With AP in Stage IIIB/IIIC/IV Non-squamous Non-small-cell Lung Cancer
ClinicalTrials.gov study NCT04012619. IPD Sharing: NO. Countries: 1. Publications: 0.
Targeted Treatment for ALK Positive Patients Who Have Previously Been Treated for Non-squamous Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT03737994. IPD Sharing: YES. Countries: 1. Publications: 0.
Phase 2 Study of GSK1363089 (Formerly XL880) in Adults With Squamous Cell Cancer of the Head and Neck
ClinicalTrials.gov study NCT00725764. IPD Sharing: YES. Countries: 1. Publications: 0.
Data from: Quantification of sensitivity and resistance of breast cancer cell lines to anti-cancer drugs using GR metrics
Open the record for dataset details and reuse information.
Indirect comparison between immunotherapy alone and immunotherapy plus chemotherapy as first-line treatment for advanced non-small cell lung cancer: A systematic review
Open the record for dataset details and reuse information.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.